Japan Energy Summit & Exhibition Opens in Tokyo with Global Leaders Calling for Energy Resilience, Strategic Investment, and Long-Term Collaboration
Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma
